Bogen KT, Sheehan PJ, Valdez-Flores C, Li AA. Reevaluation of Historical Exposures to Ethylene Oxide Among U.S. Sterilization Workers in the National Institute of Occupational Safety and Health (NIOSH) Study Cohort. Int J Environ Res Public Health. 2019 May 16;16(10).
Li AA, Makris SL, Marty MS, Strauss V, Gilbert ME, Blacker A, Zorrilla LM, Coder PS, Hannas B, Lordi S, Schneider S. Practical considerations for developmental thyroid toxicity assessments: What's working, what's not, and how can we do better? Regul Toxicol Pharmacol. 2019 Apr 21;106:111-136.
Li AA, Sheets LP, Raffaele K, Moser V, Hofstra A, Hoberman A, Makris SL, Garman R, Bolon B, Kaufmann W, Auer R, Lau E, Vidmar T, Bowers WJ. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings. Neurotoxicol Teratol. 2017 Sep;63:24-45. doi: 10.1016/j.ntt.2017.07.001. Epub 2017 Jul 27.
Li AA, Garman RH, Sheets LP, Bowers WJ, Kaufmann W, Auer RN, Bolon B. Regulatory testing for developmental neurotoxicology. In: McQueen CA, Comprehensive Toxicology, Third Edition. Vol. 9, pp. 183-215, 2018. Oxford: Elsevier Ltd.\
Aschner M, Ceccatelli S, Daneshian M, Fritsche E, Hasiwa N, Hartung T, Hogberg HT, Leist M, Li A, Mundi WR, Padilla S, Persma Ah, Bal-Price A, Seiler A, Westerink R, Zimmer B, Lein P. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX 2017. 34:49-74.
Sheets LP, Li AA, Minnema DJ, Collier RH, Creek MR, Peffer RC. A critical review of neonicotinoid insecticides for developmental neurotoxicity. Crit Rev Toxicol 2016. 46(2):153:90.
Garman RH, Li AA, Kaufmann W, Auer RN, Bolon B. Recommended methods for brain processing and quantitative analysis in rodent developmental neurotoxicity studies. Toxicol Pathol. 2016. 44:14-42.
Faber W, Kirkpatrick D, Coder P, Li A, Borghoff S, Banton M. Subchronic, reproductive, and maternal toxicity studies with tertiary butyl acetate (TBAC). Regulatory Toxicology and Pharmacology 2014; 68:332-342.
Burns CJ, McIntosh LJ, Mink PJ, Jurek AM, Li AA. Pesticide exposure and neurodevelopmental outcomes: review of the epidemiologic and animal studies. JTEH Part B 2013; 16:127-283.
Mink PJ, Kimmel CA, Li AA. Potential effects of chlorpyrifos on fetal growth outcomes: Implications for risk assessment. J Toxicol Environ Health B Crit Rev 2012;15(4):281-316.
Li, AA, Levine TE, Burns CJ, Anger WK. Integration of epidemiology and animal neurotoxicity data for risk assessment. Neurotoxicology 2012 Aug; 33(4):823-832.
Llorens J, Li A, Ceccatelli S, Sunol C. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it. Neurotoxicology 2012 Aug; 33(4):796-804.
Mink PJ, Kimmel CA, Li AA. Potential effects of chlorpyrifos on fetal growth outcomes: implications for risk assessment. JTEH Part B 2012; 15:281-316.
Bal-Price AK, Coecke S, Costa L, Crofton KM3, Fritsche E, Goldberg A, Grandjean P, Lein PL, Li A, Lucchini R, Mundy WR, Padilla S, Persico AM, Seiler AEM, Kreysa J. Advancing the Science of developmental neurotoxicity (DNT): Testing for better safety evaluation. ALTEX 2012; 29:202-215.
Li, AA, Fowles J, Banton M, Picut C, Kirkpatrick D. Acute inhalation study of allyl alcohol for derivation of acute exposure guideline levels. Inhalation Toxicology 2012; 24:213-226.
Li, AA, Lowe, KA, McIntosh, LJ, Mink, PJ. Evaluation of epidemiology and animal data for risk assessment: Chlorpyrifos developmental neurobehavioral outcomes. JTEH Part B 2012; 15:109-185.
DeSesso JM, Watson RE, Keen CL, Hazelden KP, Haws LC, Li AA. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: A case study of dimethoate. J Toxicol Environ Health Part A 2009; 94-109.
Li AA, Baum MJ, McIntosh LJ, Day M, Liu F, Gray LE. Building a scientific framework for studying hormonal effects on behavior and on the development of the sexually dimorphic nervous system. Neurotoxicology 2008; 29:504-519.
Krewski D (chair), Li AA (one of 22 authors). Toxicity testing in the 21st Century: A vision and a strategy. National Research Council of the National Academies. National Academies Press, Washington D.C., 2007. ISBN-13 978-0-309-10992-5. http://www.nap.edu.
Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, Schneider S, Silbergeld E, Reum T, Trnovec T, Monnet-Tschudi F, Bal-Price A. Work group report: Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect 2007 Jun; 115(6): 924-31.
Krewski D (chair), Li, AA (one of 22 authors). Toxicity testing for assessment of environmental agents. Committee on Toxicity Testing and Assessment of Environmental Agents. National Research Council of the National Academies. National Academies Press, Washington D.C., 2006. ISB# 0-309-10092-5. http://www.nap.edu.
Cooper RL, Lamb JC, Barlow SM, Bentley K, Brady AM, Doerrer NG, Eisenbrandt DL, Fenner-Crisp PA, Hines RN, Irvine LF, Kimmel CA, Koeter H, Li AA, Makris SL, Sheets LP, Speijers G, Whitby KE. A tiered approach to life stages testing for agricultural chemical safety assessment. Crit Rev Toxicol 2006; Jan; 36(1):69-98.
Li AA, Mink P, Mcintosh, LJ, Teta M, Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinson's Disease. J Occup Environ Med 2005; 47(10):1059-1087.
Slikker W, Acuff K, Boyes WK, Chelonis J, Crofton KM, Dearlove GE, Li A, Moser VC, Newland C, Li Rossi J, Schantz S, Sette W, Sheets L, Stanton M, Tyl S, Sobotka TJ. Behavioral test methods workshop. Neurotoxicol Teratol 2005; 27(3):417-427.
Li AA. Regulatory developmental neurotoxicology testing: Data evaluation for risk assessment purposes. Environ Toxicol Pharmacol 2005; 19(3):727-733.
Middaugh LD, Dow-Edwards D, Li AA, Sandler JD, Seed J, Sheets LP, Shuey DL, Slikker W, Weisenburger WP, Wise LD, Selwyn M. Neurobehavioral assessment: A survey of use and value in safety assessment studies. Toxicol Sci 2003; 76(2):250-261.
Dorman DC, Allen SL, Byczkowski JZ, Claudio L, Fischer JE, Fisher JW, Harry GJ, Li AA, Makris SL, Padilla S, Sultatos LG, Mileson BE. Methods to identify and characterize developmental neurotoxicity for human health risk assessment: III. Pharmacological considerations. Environ Health Perspect 2001; 109 Suppl 1:101-111.
Moser VC, Bowen SE, Li AA, Sette WS, Weisenburger WP. Cognitive evaluation: Is it needed in neurotoxicity screening? Neurotoxicol Teratol 2000; 22:7850-798.
Li AA, Thake DC, Kaempfe TA, Branch DK, O'Donnell P, Speck FL, Tyler TR, Faber WD, Jasti SL, Ouellette R, Banton MI. Neurotoxicity evaluation of rats after subchronic inhalation exposure to Isobutanol. Neurotoxicol 1999; 20(6):889-900.
Boyes WK, Dourson ML, Patterson J, Tilson HA, Sette WF, MacPhail RC, Li A, O'Donoghue JL. EPA neurotoxicity risk assessment guidelines. Fundam Appl Toxicol 1997; 40:175-184.
Albee R, Li A, Moser V, O'Donoghue J, Ross J, and Sheets L. U.S. EPA/AIHC training video and reference manual for a functional observational battery, 1996.
Li AA. Functional assessment: From benchtop to regulator. Proceedings, The Toxicology Forum, 1994 Annual Summer Meeting, The Given Institute of Pathobiology, 1994.
Li AA. The use (misuse) of schedule-controlled operant behavior in neurotoxicity testing. In: Toxicological Interpretation of Neurobehavioral Data. Weiss B and O'Donoghue J (eds), New York, Argus, 1994.
Rees DC, Li AA. Schedule-controlled operant behavior I. Identification of neurotoxicity: Critical summary of workshop discussion and implications. In: Toxicological Interpretation of Neurobehavioral Data. Weiss B and O'Donoghue J (eds), New York, Argus, 1994.
Marek GJ, Heffner TG, Shaughnessy RA, Li AA, Seiden LS. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule of reinforcement. Pharm Biochem Beh 1994.
Li AA, Asbury KJ, Hopkins WE, Feng PCC, Wilson AGE. Metabolism of alachlor by rat and monkey liver nasal turbinate tissue. Drug Metabol Disposit 1992; 20:616-618.
Li AA, Marek GJ, Hand TH, Seiden LS. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. Eur J Pharm 1990; 177:137-144.
Li AA, Marek GJ, Vosmer G, Seiden LS. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharm Biochem Beh 1989; 33:641-648.
Marek GJ, Li AA, Seiden LS. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-s behavior. J Pharmacol Exp Ther 1989; 250:60.
Marek GJ, Li A, Seiden LS. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential -reinforcement-of-low rate 72-s schedule. J Pharmacol Exp Ther 1989; 250:52-59.
Seiden LS, Marek GJ, O'Donnell JM, Li A, Dunn R, Jolly D. The role of noradrenergic and serotonergic systems in the screening of antidepressant drugs. Proceedings, 6th Club CA Symposium, Jerusalem, Israel, June 1987.
Lectures and Symposia
Li AA. Weight of evidence (WOE) and Benchmark dose (BMD) analysis: Brain morphometry and startle behavior as examples. Teratology Society Meeting, Montreal, Canada, June, 2015.
Li AA, Bowers W (Workshop Chairs). Regulatory neurodevelopmental testing: New guiding principles for harmonizing of data collection analysis. Society of Toxicology Meeting, San Diego, CA. March 24, 2015.
Li AA, Polakoff B. Analysis of EPA FQPA safety factors for 363 pesticides. Presented in session "Enhancing Strategies for Pesticide Risk Assessment," Society of Toxicology, Phoenix, AZ, March 24, 2014.
Li AA, Polakoff B. FQPA and health effects. Symposium Regulatory Risk Assessment: New Paradigms for Human Health Exposure Considerations for Dietary, Aggregate, Cumulative and FQPA, American Chemistry Society Meeting, Indianapolis, IN, September 12, 2013.
Li AA, Zeise L (Workshop Chairs). Bridging the green chemistry gap. Society of Toxicology Meeting, San Francisco, CA, 2012.
Li AA (Symposium Chair and lecturer). Integration of animal data for risk assessment. International Neurotoxicology Association Biennual Meeting, Xi'an, China, June 2011.
Li, A.A. (Lecturer) 2010. Developmental Neurotoxicity Testing: Current Approaches and Future Trends. Lecture to FDA reviewers and scientists from the Division of Food Contact Notifications (DFCN), Office of Food Additive Safety (OFAS), Center for Food Safety and Applied Nutrition. November, 2010.
Li AA (Workshop Panelist). Computational toxicology: From data to analyses to applications. National Academy of Science Emerging Science for Environmental Health Decisions, Washington D.C., September 2009. http://dels.nas.edu/envirohealth/sept_participantinfo.shtml.
Li AA, Levine T. (Session Chairs and Speakers). Pesticides and Parkinson's disease: Implications of new epidemiology and exposure data to risk assessment. Session Talk by Abby Li: Pesticide risk assessment and animal models of PD. Society of Toxicology Annual Meeting, Baltimore, MD, March 2008.
Li AA, Gray LE (Session Chairs and Speakers). Developing a framework for studying hormonal effect on sexual differentiation of the brain. International Neurotoxicology Association Meeting, Pacific Grove, CA, June 2007.
Li AA. Developmental neurotoxicology testsmart: Validation for what purpose? Center for Alternatives to Animal Testing, Reston, VA, March 2006.
Li AA. From rat to human: risk assessment for developmental neurotoxicology studies (DNT). Summer Toxicology Forum, Aspen, CO, July 2003.
Li AA, Maurissen J, Mundy W, Crofton K. Developmental neurotoxicology: data interpretation and risk assessment. International Neurotoxicology Association 9, Dresden, Germany, June 2003.
Li AA, Barnett JF, Maurissen J. Developmental neurotoxicity testing, testing and data interpretation. Invited lecturer for continuing education course on mechanisms, biomarkers, data interpretation: An integrative risk assessment using DNT as a model. Teratology Society Meeting, Scottsdale, AZ, June 2002.
Li AA. Neurotoxicology of Triallate, a thiocarbamate. International Neurotoxicology Association Meeting, Estoril, Portugal, June 2001.
Li AA. Neurotoxicology. Invited Lecturer to American Industrial Hygiene Association Toxicology Course, Redondo Beach, CA August 2000; Williamsburg, VI, August 1999.
Li AA. The value of developmental neurotoxicology testing. Winter Toxicology Forum, Washington D.C., November 1999.
Li AA. Implications of EPA's Neurotoxicity Risk Assessment Guidelines from a FIFRA Perspective. EPA's Neurotoxicity Risk Assessment Guidelines Workshop, Society of Toxicology, March 1997.
Li AA. Industry Perspective on EPA's Proposed Neurotoxicology Risk Assessment Guidelines. Summer Toxicology Forum, Aspen, Colorado, July 10, 1996.
Li AA. Session Organizer: Neurotoxicity testing: Are we on the right track? 5th International Neurotoxicity Association Meeting, Port Ludlow, WA, June 1995.
Li AA. Neurotoxicological evaluations in adult animal studies. American College of Toxicology, 15th Annual Meeting, Williamsburg, VI, October 23, 1994.
Li AA. 1994. Functional testing: from benchtop to regulator. Annual Summer Toxicology Forum, Given Institute of Pathobiology, Aspen, CO, July 12, 1994.
Li, A.A. An industrial perspective of neurotoxicity toxicity testing. University of Washington, Department of Environmental Health School of Public Health and Community Medicine, Seattle, WA, May 19, 1994.
Li AA. FDA Redbook II: Industry's response to neurotoxicity test guidelines. Conference on the U.S. Food and Drug Administration's Redbook II, sponsored by the International Life Sciences Institute, Washington D.C., December 17, 1993.
Li AA. Neurotoxicity testing. CliniChem-93, Sponsored by the American Association for Clinical Chemistry, Albany, NY, October 15, 1993.
Li AA. Invited lecture to EPA toxicology reviewers: neurotoxicity testing: Introduction to conduct of studies and interpretation of data. Environmental Protection Agency, Crystal City, VI, April 28, 1993.
Li AA. Neurotoxicity testing. University of Washington, Department of Environmental Health School of Public Health and Community Medicine, Seattle, WA, April 8, 1993.
Li AA. Neurotoxicity screening battery. Symposium on Occupational and Environmental Neurotoxicology, Northwest Center for Occupational Health and Safety (supported by National Institute for Occupational Safety and Health), Seattle, WA, March 11, 1993.
Li AA. Neurotoxicity testing in animals. Occupational and Environmental Toxicology Symposium, sponsored by the Northwest Center for Occupational Health and Safety and University of Washington, Seattle, WA, March 11, 1993.
Li AA. The use (misuse) of schedule-controlled operant behavior in regulatory testing. 18th Rochester Conference: Toxicological Interpretation of Neurobehavioral Data, Rochester, NY, June 1992.
Li AA. Neurobehavioral testing: The good, the bad, and the ugly. Society of Toxicologic Pathologists, 11th International Symposium, Neuropathology/Neurotoxicology Workshop, Phoenix, AZ, June 5-6, 1992.